Retrospective Cohort Study
Copyright ©The Author(s) 2023.
World J Gastrointest Surg. Aug 27, 2023; 15(8): 1641-1651
Published online Aug 27, 2023. doi: 10.4240/wjgs.v15.i8.1641
Table 1 Baseline features of the study population
CharacteristicBefore PSM
After PSM
SPD group
TIPS group
P value
SPD group
TIPS group
P value
Age, yr44.14 ± 10.6449.57 ± 11.24< 0.00146.41 ± 10.8147.16 ± 10.950.65
Male, n (%)121 (74.7)105 (67.3)0.1564 (71.1)60 (66.7)0.520
Bleeding history, mo12.70 ± 24.1912.83 ± 21.950.96113.64 ± 26.7613.6 ± 22.620.99
Spleen length, cm20.121 ± 4.4919.27 ± 4.050.0819.86 ± 4.4718.85 ± 3.570.10
Spleen thickness, cm6.47 ± 1.436.20 ± 1.420.096.31 ± 1.296.05 ± 1.070.14
TB, μmol/L22.81 ± 9.9322.18 ± 10.220.5823.68 ± 10.6021.99 ± 9.650.26
ALT, IU/L34.561 ± 27.6832.08 ± 35.490.4929.81 ± 19.3329.34 ± 15.250.86
AST, IU/L40.651 ± 29.0541.218 ± 35.800.8836.37 ± 22.7837.32 ± 18.090.76
ALB, g/L37.71 ± 5.2833.13 ± 6.19< 0.00136.35 ± 4.5835.46 ± 5.150.22
A/G1.311 ± 0.291.52 ± 3.400.451.31 ± 0.271.28 ± 0.290.58
ALP, IU/L87.10 ± 39.9885.08 ± 52.930.7086.42 ± 37.5086.93 ± 57.340.94
GGT, IU/L50.13 ± 59.9449.26 ± 61.590.9053.35 ± 71.0349.14 ± 63.910.68
BUN, mmol/L6.038 ± 7.875.89 ± 2.760.826.48 ± 10.445.56 ± 2.000.42
CREA, μmol/L72.92 ± 17.0173.02 ± 18.400.9673.20 ± 18.5469.36 ± 14.590.13
HGB, g/L99.74 ± 27.8584.38 ± 23.18< 0.00194.42 ± 30.0291.07 ± 23.760.41
RBC, × 1012/L3.71 ± 0.823.06 ± 0.79< 0.0013.46 ± 0.813.39 ± 0.790.54
PLT, × 109/L51.85 ± 43.1155.13 ± 37.110.4750.76 ± 45.6252.86 ± 24.490.70
WBC, × 109/L3.68 ± 3.853.59 ± 3.930.833.10 ± 2.563.38 ± 2.260.43
PT, s14.67 ± 3.7914.76 ± 2.080.7914.38 ± 1.9514.21 ± 1.750.54
INR1.27 ± 0.171.32 ± 0.190.021.28 ± 0.171.27 ± 0.150.46
HBV-DNA Positive80 (49.4)81 (51.9)0.6547 (52.2)48 (53.3)0.88
Child-Pugh classification, n (%)0.171.00
A89 (54.9)75 (48.1)49 (54.4)49 (54.4)
B73 (45.1)81 (51.9)41 (45.6)41 (45.6)
Severe EGV, n (%)131 (80.9)124 (79.5)0.7873 (81.1)74 (82.2)1.00